c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein

Endocrinology

Volumn 153, Issue 2, 2012, Pages 861-872

  Sicari, Brian M ^a   Troxell, Ronnie ^a   Salim, Fatimah ^a   Tanwir, Mansoor ^a   Takane, Karen K ^a   Fiaschi Taesch, Nathalie ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PARATHYROID HORMONE RELATED PROTEIN; PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; GENE TARGETING; MOLECULAR MECHANICS; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RAT; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL CYCLE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENE EXPRESSION REGULATION; MICE; MUSCLE, SMOOTH, VASCULAR; MUTATION; NEOINTIMA; PARATHYROID HORMONE-RELATED PROTEIN; PROTO-ONCOGENE PROTEINS C-MYC; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; S-PHASE KINASE-ASSOCIATED PROTEINS;

EID: 84856090603     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1590     Document Type: Article

References (42)

1. Tanner FC, Boehm M, Akyürek LM, San H, Yang ZY, Tashiro J, Nabel GJ, Nabel EG 2000 Differential effects of the cyclin-dependent kinase inhibitors p27(KIP1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Circulation 101:2022-2025 (Pubitemid 30233162)
2. Boehm M, Olive M, True AL, Crook MF, San H, Qu X, Nabel EG 2004 Bone marrow-derived immune cells regulate vascular disease through a p27 (KIP1)-dependent mechanism. J Clin Invest 114:419-426 (Pubitemid 39071614)
3. Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ, Nabel EG 1998 Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res 82:396-403 (Pubitemid 28101197)
4. Carter AJ, Aggarwal M, Kopia GA, Tio F, Tsao PS, Kolata R, Yeung AC, Llanos G, Dooley J, Falotico R 2004 Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 63:617-624 (Pubitemid 39078675)
5. Sun J, Marx SO, Chen HJ, Poon M, Marks AR, Rabbani LE 2001 Role for p27(KIP1) in vascular smooth muscle cell migration. Circulation 103:2967-2972 (Pubitemid 32578136)
6. Chu IM, Hengst L, Slingerland JM 2008 The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer 8:253-267 (Pubitemid 351430863)
7. KIP1KIP1. Genes Dev 11:1464-1478
8. Vlach J, Hennecke S, Amati B 1997 Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27kip1. EMBO J 16:5334-5344 (Pubitemid 27380141)
9. kip1 is instigated by Jab1. Nature 398:160-165
10. Wu YJ, Bond M, Sala-Newby GB, Newby AC 2006 Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation. Circ Res 98:1141-1150 (Pubitemid 43948100)
11. Bond M, Wu YJ, Sala-Newby GB, Newby AC 2008 Rho GTPase, Rac1, regulates Skp2 levels, vascular smooth muscle cell proliferation, and intima formation in vitro and in vivo. Cardiovasc Res 80:290-298
12. Wu YJ, Sala-Newby GB, Shu KT, Yeh HI, Nakayama KI, Nakayama K, Newby AC, Bond M 2009 S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo. J Vasc Surg 50:1135-1142
13. Dang CV 1999 c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19:1-11 (Pubitemid 29018404)
14. Nasi S, Ciarapica R, Jucker R, Rosati J, Soucek L 2001 Making decisions through Myc. FEBS Lett 490:153-162 (Pubitemid 32171934)
15. Bennett MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI 1994 Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J Clin Invest 93:820-828 (Pubitemid 24072825)
16. Kipshidze NN, Kim HS, Iversen P, Yazdi HA, Bhargava B, New G, Mehran R, Tio F, Haudenschild C, Dangas G, Stone GW, Iyer S, Roubin GS, Leon MB, Moses JW 2002 Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model. J Am Coll Cardiol 39:1686-1691 (Pubitemid 34494294)
17. Broadus AE, Mangin M, Ikeda K, Insogna KL, Weir EC, Burtis WJ, Stewart AF 1988 Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide. N Engl J Med 319:556-563
18. Burtis WJ, Brady TG, Orloff JJ, Ersbak JB, Warrell Jr RP, Olson BR, Wu TL, Mitnick ME, Broadus AE, Stewart AF 1990 Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med 322:1106-1112 (Pubitemid 20149527)
19. Philbrick WM, Wysolmerski JJ, Galbraith S, Holt E, Orloff JJ, Yang KH, Vasavada RC, Weir EC, Broadus AE, Stewart AF 1996 Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev 76:127-173 (Pubitemid 26048280)
20. Ozeki S, Ohtsuru A, Seto S, Takeshita S, Yano H, Nakayama T, Ito M, Yokota T, Nobuyoshi M, Segre GV, Yamashita S, Yano K 1996 Evidence that implicates the parathyroid hormone-related peptide in vascular stenosis. Increased gene expression in the intima of injured carotid arteries and human restenotic coronary lesions. Arterioscler Thromb Vasc Biol 16:565-575 (Pubitemid 26107728)
21. Nakayama T, Ohtsuru A, Enomoto H, Namba H, Ozeki S, Shibata Y, Yokota T, Nobuyoshi M, Ito M, Sekine I 1994 Coronary atherosclerotic smooth muscle cells overexpress human parathyroid hormone-related peptides. Biochem Biophys Res Commun 200:1028-1035 (Pubitemid 24146065)
22. Massfelder T, Dann P, Wu TL, Vasavada R, Helwig JJ, Stewart AF 1997 Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting. Proc Natl Acad Sci USA 94:13630-13635
23. de Miguel F, Fiaschi-Taesch N, López-Talavera JC, Takane KK, Massfelder T, Helwig JJ, Stewart AF 2001 The C-terminal region of PTHrP, in addition to the nuclear localization signal, is essential for the intracrine stimulation of proliferation in vascular smooth muscle cells. Endocrinology 142:4096-4105 (Pubitemid 32802683)
24. Nguyen MT, Karaplis AC 1998 The nucleus: a target site for parathyroid hormone-related peptide (PTHrP) action. J Cell Biochem 70:193-199 (Pubitemid 28308928)
25. Lam MH, House CM, Tiganis T, Mitchelhill KI, Sarcevic B, Cures A, Ramsay R, Kemp BE, Martin TJ, Gillespie MT 1999 Phosphorylation at the cyclin-dependent kinases site (Thr85) of parathyroid hormone-related protein negatively regulates its nuclear localization. J Biol Chem 274:18559-18566
26. Fiaschi-Taesch N, Takane KK, Masters S, Lopez-Talavera JC, Stewart AF 2004 Parathyroid hormone-related protein as a regulator of pRb and the cell cycle in arterial smooth muscle. Circulation 110:177-185 (Pubitemid 38924586)
27. Fiaschi-Taesch N, Sicari BM, Ubriani K, Bigatel T, Takane KK, Cozar-Castellano I, Bisello A, Law B, Stewart AF 2006 Cellular mechanism through which parathyroid hormone-related protein induces proliferation in arterial smooth muscle cells: definition of an arterial smooth muscle PTHrP/p27kip1 pathway. Circ Res 99:933-942 (Pubitemid 44657796)
28. Fiaschi-Taesch N, Sicari B, Ubriani K, Cozar-Castellano I, Takane KK, Stewart AF 2009 Mutant parathyroid hormone-related protein, devoid of the nuclear localization signal, markedly inhibits arterial smooth muscle cell cycle and neointima formation by coordinate up-regulation of p15Ink4b and p27kip1. Endocrinology 150:1429-1439
29. Fiaschi-Taesch NM, Salim F, Kleinberger J, Troxell R, Cozar-Castellano I, Selk K, Cherok E, Takane KK, Scott DK, Stewart AF 2010 Induction of human β-cell proliferation and engraftment using a single G1/S regulatory molecule, cdk6. Diabetes 59:1926-1936
30. He B, Deckelbaum RA, Miao D, Lipman ML, Pollak M, Goltzman D, Karaplis AC 2001 Tissue-specific targeting of the pthrp gene: the generation of mice with floxed alleles. Endocrinology 142:2070-2077 (Pubitemid 32405966)
31. Kirby BJ, Ardeshirpour L, Woodrow JP, Wysolmerski JJ, Sims NA, Karaplis AC, Kovacs CS 2011 Skeletal recovery after weaning does not require PTHrP. J Bone Miner Res 26:1242-1251
32. Sipula D, García-Ocaña A, Karaplis AC, Vasavada RC, Conditional knockout of parathyroid hormone-related protein (PTHrP) in β cells causes resistance to β cell death. 63rd Annual Meeting of the American Diabetes Association, New Orleans, 2003
33. VanHouten JN, Dann P, Stewart AF, Watson CJ, PollakM,Karaplis AC, Wysolmerski JJ 2003 Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation. J Clin Invest 112:1429-1436
34. Shi Y, Fard A, Galeo A, Hutchinson HG, Vermani P, Dodge GR, Hall DJ, Shaheen F, Zalewski A 1994 Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury. Circulation 90:944-951
35. Barchiesi F, Jackson EK, Fingerle J, Gillespie DG, Odermatt B,Dubey RK 2006 2-Methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blockade of the cell cycle. Circ Res 99:266-274 (Pubitemid 44174934)
36. Chen SJ, Chen YF, Miller DM, Li H, Oparil S 1994 Mithramycin inhibits myointimal proliferation after balloon injury of the rat carotid artery in vivo. Circulation 90:2468-2473 (Pubitemid 24354335)
37. Kanse SM, Benzakour O, Kanthou C, Kost C, Lijnen HR, Preissner KT 1997 Induction of vascular SMC proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders. Arterioscler Thromb Vasc Biol 17:2848-2854 (Pubitemid 28016031)
38. Hershko DD 2008 Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer. Cancer 112:1415-1424 (Pubitemid 351441154)
39. von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, Cetinkaya C, Hydbring P, Weidung I, Nakayama K, Nakayama KI, Söderberg O, Kerppola TK, Larsson LG 2003 The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 11:1189-1200 (Pubitemid 36645139)
40. Kim SY, Herbst A, Tworkowski KA, Salghetti SE, Tanseyn WP 2003 Skp2 regulatesMycprotein stability and activity.MolCell 11:1177-1188
41. Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, Park HJ, Tan Y, Ackerson T, Costa RH 2005 Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol 25:10875-10894 (Pubitemid 41747132)
42. Costa RH 2005 FoxM1 dances with mitosis. Nat Cell Biol 7:108-110 (Pubitemid 40268125)